by Allyson Lock | Jan 21, 2023 | News | 0 comments Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease